Stockscreener 앱 받기
58.02
2.13%
-1.26
시장 영업 전:
57.91
-0.11
-0.19%
전일 마감가:
$59.28
열려 있는:
$58.97
하루 거래량:
8.98M
Relative Volume:
1.57
시가총액:
$22.75B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
40.62
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
-14.93%
1개월 성능:
-12.57%
6개월 성능:
-28.84%
1년 성능:
-15.44%
1일 변동 폭
$56.89
$60.00
1주일 범위
$56.45
$62.39
52주 변동 폭
$56.45
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
58.02 | 23.12B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
124.95 | 216.56B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
99.05 | 146.61B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.81 | 136.78B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.06 | 115.95B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.44 | 48.64B | 5.88B | 1.34B | 577.90M | 2.3455 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Arkadios Wealth Advisors Acquires Shares of 2,485 DexCom, Inc. $DXCM - Defense World
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class ActionDXCM - NewMediaWire
Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ) - DexCom Investor Relations
ROSEN, SKILLED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDXCM - MarketScreener
Key facts: Class action lawsuit filed against DexCom; strong demand reported - TradingView
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
Kaplan Fox Alerts Investors of DexCom, Inc. (DXCM) to a Securities Class Action Deadline on December 26, 2025 - Markets Financial Content
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. InvestorsLead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
Will DexCom Inc. stock continue dividend increasesMarket Sentiment Review & Safe Capital Growth Stock Tips - newser.com
Portnoy Law Firm Announces Class Action on Behalf of DexCom, Inc. Investors - GlobeNewswire
From Dividends to Growth: Why These 3 Stocks Stand Out in 2025 - Investing.com
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for InvestorsContact The Gross Law Firm - MarketScreener
Is DexCom Inc. (DC4) stock a top pick for value investorsTrend Reversal & Low Risk Entry Point Guides - newser.com
We Like DexCom's (NASDAQ:DXCM) Earnings For More Than Just Statutory Profit - Yahoo Finance
Has DexCom Inc. found a price floor2025 Risk Factors & Real-Time Stock Entry Alerts - newser.com
Statistical indicators supporting DexCom Inc.’s strengthJuly 2025 Momentum & Verified Momentum Watchlists - newser.com
The 5 Most Interesting Analyst Questions From DexCom’s Q3 Earnings Call - Yahoo Finance
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds DexCom, Inc. (DXCM) Investors of December 26, 2025 Deadline - ACCESS Newswire
Lost Money on DexCom, Inc. (DXCM)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - NewMediaWire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDXCM - MarketScreener
Contact The Gross Law Firm by December 26, 2025 Deadline to Join Class Action Against DexCom, Inc.(DXCM) - GlobeNewswire
DXCM: Kirby McInerney LLP Advises DexCom, Inc. Investors of Class Action Lawsuit - GlobeNewswire
Recover Investment Losses: Class Action Initiated Against DexCom, Inc. (DXCM) - ACCESS Newswire
How DexCom Inc. stock performs in interest rate cyclesJuly 2025 WrapUp & Risk Adjusted Buy/Sell Alerts - fcp.pa.gov.br
Dexcom recalls G6 continuous glucose monitoring app - Modern Healthcare
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
December 26, 2025 Deadline: Join Class Action Lawsuit Against DexCom, Inc. (DXCM)Contact Levi & Korsinsky - ACCESS Newswire
DEXCOM CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
DEXCOM CLASS ACTION LAWSUIT: DexCom, Inc. (NASDAQ:DXCM) - GlobeNewswire
DexCom, Inc. Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
Building trade automation scripts for DexCom Inc.M&A Rumor & Growth Oriented Trade Recommendations - newser.com
Can DexCom Inc. stock maintain operating margins2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Will breakout in DexCom Inc. lead to full recoveryMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
DexCom Inc. stock outlook for YEARIndex Update & Weekly Stock Performance Updates - newser.com
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky to Join Class Action Before December 26, 2025 - ACCESS Newswire
Will DexCom Inc. stock maintain momentum in 2025Market Trend Summary & Daily Oversold Stock Bounce Ideas - newser.com
What catalysts could drive DexCom Inc. stock higherPortfolio Value Report & Daily Stock Momentum Reports - newser.com
What does recent volatility data suggest for DexCom Inc.2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com
Is DexCom Inc. (DC4) stock supported by free cash flow2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
DexCom Inc. stock chart pattern explainedJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Will a bounce in DexCom Inc. offer an exit2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com
Join Class Action to Recover Losses from DexCom, Inc. (DXCM)Contact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit - Your Wyoming Link
Levi & Korsinsky Moves to SueWallSt for DexCom, Inc. Investors That Lost Money - ACCESS Newswire
DexCom (NASDAQ:DXCM) Price Target Lowered to $95.00 at UBS Group - MarketBeat
Securities Fraud Class Action Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Reminds Investors of December 26, 2025 - ACCESS Newswire
DXCM Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - NewMediaWire
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important ... - Bluefield Daily Telegraph
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. - GlobeNewswire
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.85%
1.90%
자본화:
|
볼륨(24시간):